Greater weight loss efficacy of tirzepatide 10 mg ( 3.2 kg) and 15 mg ( 5.2 kg) compared to semaglutide was also observed in an indirect comparison with data from the SUSTAIN FORTE study, where semaglutide was administered at the maximum hypoglycemic dose of 2.0 mg [49]
Since last year, Medicare has covered the weight-loss formulations of GLP-1 products under its Part D (outpatient) drug program if beneficiaries had a separate Food and Drug Administration-approved indication
ZEPBOUND (tirzepatide) injection - Prescribing Information
Ancak Zepbound her ikisini de harekete geirir: GLP-1 reseptrleri GIP reseptrleri Bu birleik etki, vcutta daha kapsaml bir yant oluturur
Notice also that the p K a scale is logarithmic, so even a small difference, lets say p K a 1 = 16 and p K a2 = 19, represents 3 p K a units, which means the first compound is 10 3 or 1,000 times more acidic than the second compound
This makes it even more effective for weight loss and blood sugar management